Recommended Procedure for Pleurodesis
Talc is the most effective sclerosing agent for pleurodesis, with a success rate of 93%, and should be administered either as talc slurry through a chest tube or as talc poudrage via thoracoscopy. 1
Patient Selection and Preparation
- Patients selected for pleurodesis should have significant symptoms that are relieved when pleural fluid is evacuated 1
- Complete re-expansion of the lung without evidence of bronchial obstruction or fibrotic trapped lung is essential for successful pleurodesis 1, 2
- Absolute contraindications include trapped lung and mainstem bronchial obstruction, as these prevent the necessary apposition of pleural surfaces 2
- Relative contraindications include massive pleural effusion with rapid re-accumulation, short life expectancy, active pleural infection, and concurrent corticosteroid therapy 2
Procedure for Talc Slurry Pleurodesis
- Insert a small-bore intercostal tube (10-14 F), which is the recommended initial choice for effusion drainage and pleurodesis 1
- Drain the pleural space completely to ensure full lung re-expansion 1
- Confirm complete lung re-expansion and proper tube position with chest radiograph 1
- Administer premedication with intravenous narcotic and anxiolytic-amnestic agents before the procedure 1
- Instill lignocaine solution (3 mg/kg; maximum 250 mg) into the pleural space 1
- Prepare talc slurry by mixing 4-5 g of talc with 50 ml of normal saline 1
- Instill the talc slurry through the chest tube when minimal or no pleural fluid remains and complete lung expansion is confirmed 1
- Clamp the chest tube for 1 hour after talc instillation 1
- Patient rotation is recommended during the clamping period to ensure even distribution of the talc 1
- After unclamping, maintain the patient on -20 cm H₂O suction 1
- Remove the chest tube when 24-hour drainage is less than 100-150 ml 1
- If drainage remains excessive (≥250 ml/24 h) after 48-72 hours, repeat talc instillation at the same dose 1
Procedure for Talc Poudrage via Thoracoscopy
- Perform thoracoscopy under local anesthesia with conscious sedation or by video-assisted thoracoscopic surgery (VATS) 1
- Remove all pleural fluid during thoracoscopy 1
- Ensure complete collapse of the lung for optimal visualization and distribution of talc 1
- Administer approximately 5 g (8-12 ml) of talc as a powder spray over the pleural surface 1
- Inspect the pleural cavity after insufflation to ensure even distribution of talc 1
- Insert a 24-32F chest tube 1
- Apply graded and progressive suction until daily fluid drainage is less than 100 ml 1
Alternative Sclerosing Agents
If talc is unavailable, alternative agents can be used, though with lower success rates:
- Doxycycline: 500 mg mixed with 50-100 ml of sterile saline, with success rates of 72-80% 1
- Bleomycin: 60 units mixed with 50-100 ml of sterile saline, with success rates of 54% 1, 3
Management of Pleurodesis Failure
- Initial failure may result from suboptimal technique or inappropriate patient selection 1
- Options for management of failed pleurodesis include:
Common Complications and Management
- Pain and fever are the most common adverse effects of pleurodesis 1
- Chest pain occurs in 14-40% of patients undergoing talc pleurodesis 2, 4
- Fever occurs in approximately 10-24% of patients 2, 4
- Adequate analgesia and antipyretics should be provided to manage these symptoms 2
- Serious complications such as respiratory failure and ARDS are rare but more common with small-particle talc; therefore, large-particle talc is recommended 2, 5
Efficacy Considerations
- Talc pleurodesis has a success rate of approximately 90% at 30 days and 76-80% at 180 days 4
- Thoracoscopic talc poudrage appears to be more effective than bedside talc slurry, with a relative risk of non-recurrence of 1.19 in favor of thoracoscopic approach 6
- Pleural fluid pH and adenosine deaminase levels are independent predictors of talc pleurodesis outcome 7